INSIGHTS ON CLINICAL TRIAL DESIGN

• Antibody-Drug Conjugates: 'Magic Bullets' Become Reality

  Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including antibody-drug conjugates (ADCs). Learn more about ADCs’ makeup, mechanisms, and the development landscape.

• Why Early Phase Speed Depends On Oncology Expertise

  Early phase oncology speed depends on confident, oncology‑specific decisions made upfront. Learn why scientific expertise, realistic planning, and foresight determine whether programs maintain momentum.

• Evidence Of An Industry's Readiness To Collaborate

  The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.

• Patient Liaison Support In Rare Disease Trials

  Real stories from rare disease trials show how attentive communication, logistical coordination, and timely reimbursement reduce stress for participants while keeping long-term engagement.

• The Neural Crystal Ball: Forecasting Future CNS Drug Development

  4/15/2026

  Advances in the industry are redefining how we treat neurological and psychiatric disorders. In this presentation, Dr. Beatrice Setnik examines the trends and innovations shaping the next generation of therapies.

• Pioneering Clinical Research For Native American Communities In South Dakota

  1/31/2025

  Lynn Bartholow is transforming clinical research for Native American populations. Explore her journey into clinical research and efforts to build trust and foster participation and community engagement.

• Reducing Supply Risk in Cell & Gene Therapy Trials

  7/31/2026

  In cell and gene therapy trials, success depends on coordination. Learn how visibility, workflow control, and alignment help reduce risk and protect patient-specific treatments.

• All You Need To Know About 505(b)(2), But Were Afraid To Ask

  7/18/2025

  Join us to explore the 505(b)(2) pathway. Learn how to bring improved drugs to market faster, reduce costs, and add value with this streamlined regulatory approach.

• Disclosure Management System: Build Or Buy?

  6/19/2025

  Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.